Discontinuation report MYLAN-CELECOXIB
Report ID | 30337 |
Drug Identification Number | 02423278 |
Brand name | MYLAN-CELECOXIB |
Common or Proper name | CELECOXIB |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-07-03 |
Actual discontinuation date | 2018-07-03 |
Remaining supply date | 2018-07-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Discontinued in ID shortage 134. Last Lot 3087719 Expires 31-Mar-2019 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-07-04 | English | Compare |
v11 | 2018-07-03 | French | Compare |
v10 | 2018-07-03 | English | Compare |
v9 | 2018-07-03 | French | Compare |
v8 | 2018-07-03 | English | Compare |
v7 | 2018-04-03 | French | Compare |
v6 | 2018-04-03 | English | Compare |
v5 | 2018-02-21 | French | Compare |
v4 | 2018-02-21 | English | Compare |
v3 | 2018-02-21 | English | Compare |
v2 | 2017-11-23 | French | Compare |
v1 | 2017-11-23 | English | Compare |
Showing 1 to 12 of 12